1. Market Research
  2. > Healthcare
  3. > Medical Device Market Trends
  4. > aap Implantate AG (AAQ) - Product Pipeline Analysis, 2016 Update

Summary

aap Implantate AG (aap) is a medical device company that develops, manufactures and markets orthopedic products, biomaterials and trauma products. The company’s biomaterials include bone cements and accessories, bone substitutes, and collagen fleeces. It offers services such as product development, registrations and other regulatory processes. aap also develop new novel technologies to solve complex clinical problems. The company’s implants support minimally-invasive surgeries. Its products are used in the orthopedic specialty areas of trauma, spine repair, and others. The company has presence in Germany and the US. aap is headquartered in Berlin, Germany.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company aap Implantate AG
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table Of Contents

aap Implantate AG (AAQ) - Product Pipeline Analysis, 2016 Update
Table of Contents
Table of Contents 2


aap Implantate AG Company Overview 5
aap Implantate AG Company Snapshot 5
aap Implantate AG Pipeline Products and Clinical Trials Overview 6
aap Implantate AG - Pipeline Analysis Overview 8
Key Facts 8
aap Implantate AG - Major Products and Services 9
aap Implantate AG Pipeline Products by Development Stage 10
aap Implantate AG Pipeline Products Overview 12
Ag Cement 12
Ag Cement Product Overview 12
APS Autodynamic Plating System 13
APS Autodynamic Plating System Product Overview 13
Loqteq Plate 14
Loqteq Plate Product Overview 14
Magnesium Based LOQTEQ Implant 15
Magnesium Based LOQTEQ Implant Product Overview 15
PMMA Augmented LOQTEQ Implant 16
PMMA Augmented LOQTEQ Implant Product Overview 16
Vertolast 17
Vertolast Product Overview 17
aap Implantate AG - Key Competitors 18
aap Implantate AG - Key Employees 19
aap Implantate AG - Locations And Subsidiaries 20
Head Office 20
Other Locations and Subsidiaries 20
Recent Developments 21
aap Implantate AG, Recent Developments 21
Apr 29, 2016: aap Implantate Annual financial statements for 2015 21
Apr 22, 2016: aap Implantate reports Annual financial results for 2015 22
Feb 18, 2016: Outlook for financial year 2016: aap aims for more than 20% trauma sales growth 23
Jan 26, 2016: aap submits CE marking application for its innovative antibacterial silver coating technology 24
Jan 18, 2016: aap: Sales in Q4/2015 at EUR 6.7 million and in FY/2015 at EUR 28.7 million 24
Nov 13, 2015: aap: Q3/2015 sales and EBITDA in line with expectations 25
Oct 13, 2015: aap: Q3/2015 sales with EUR 8.4 million (+7%) in line with expectations; strong quarter in Biomaterials business (+27%) 26
Aug 14, 2015: aap: Q2/2015 sales and EBITDA above guidance; further continuous sales growth in Trauma business and with LOQTEQ 26
Jul 16, 2015: aap: Q2/2015 sales above guidance at EUR 6.5 million; 27% LOQTEQ growth in H1/2015 27
Jul 03, 2015: aap: Supervisory Board extends contract of CFO Marek Hahn prematurely until end of 2017 27
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
aap Implantate AG Pipeline Products and Clinical Trials Overview 6
aap Implantate AG Pipeline Products by Equipment Type 6
aap Implantate AG Pipeline Products by Indication 7
aap Implantate AG, Key Facts 8
aap Implantate AG, Major Products and Services 9
aap Implantate AG Number of Pipeline Products by Development Stage 10
aap Implantate AG Pipeline Products Summary by Development Stage 11
Ag Cement - Product Status 12
Ag Cement - Product Description 12
APS Autodynamic Plating System - Product Status 13
APS Autodynamic Plating System - Product Description 13
Loqteq Plate - Product Status 14
Loqteq Plate - Product Description 14
Magnesium Based LOQTEQ Implant - Product Status 15
Magnesium Based LOQTEQ Implant - Product Description 15
PMMA Augmented LOQTEQ Implant - Product Status 16
PMMA Augmented LOQTEQ Implant - Product Description 16
Vertolast - Product Status 17
Vertolast - Product Description 17
aap Implantate AG, Key Employees 19
aap Implantate AG, Subsidiaries 20

List of Figures
aap Implantate AG Pipeline Products by Equipment Type 7
aap Implantate AG Pipeline Products by Development Stage 10

Companies Mentioned
TiGenix NV
MEDICREA Group
HumanOptics AG

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
3D Cell Culture Technologies Patent Landscape

3D Cell Culture Technologies Patent Landscape

  • $ 5489
  • Company report
  • September 2016
  • by KnowMade

IP landscape for 3D cell culture technologies offers an important space to big entities as well as for small companies 3D CELL CULTURE : REPRODUCING AN IN VIVO-LIKE ENVIRONMENT IN VITRO The patent landscape ...

Glucose Dependent Insulinotropic Receptor (G Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H2 2016

Glucose Dependent Insulinotropic Receptor (G Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Glucose Dependent Insulinotropic Receptor (G Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Glucose Dependent Insulinotropic Receptor (G Protein ...

Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1) - Pipeline Review, H2 2016

Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Plasminogen Activator Inhibitor 1 (Endothelial ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.